The NF-κB pathway is rarely spontaneously activated in mantle cell lymphoma (MCL) cell lines and patient’s samples
- 1 January 2014
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 50 (1) , 159-169
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeuticsNature Reviews Cancer, 2007
- Control of B Lymphocyte Apoptosis by the Transcription Factor NF-κBImmunity, 2006
- The alternative NF-κB pathway from biochemistry to biology: Pitfalls and promises for future drug developmentBiochemical Pharmacology, 2006
- NF-κB guides the survival and differentiation of developing lymphocytesCell Death & Differentiation, 2006
- The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 statusBlood, 2006
- Control of lymphocyte development by nuclear factor-κBNature Reviews Immunology, 2005
- Interruption of the NF-κB pathway by Bay 11-7082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cellsBlood, 2004
- Inhibition of Constitutive NF-κB Activation in Mantle Cell Lymphoma B Cells Leads to Induction of Cell Cycle Arrest and ApoptosisThe Journal of Immunology, 2003
- The proteasome: structure, function, and role in the cellCancer Treatment Reviews, 2003
- Rel/NF‐κB transcription factors: key mediators of B‐cell activationImmunological Reviews, 2000